← Open Payments lookup

MARY BREWER: Open Payments

NPI 1255943932 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$540 in 29 payments from 15 companies in 2025. Trend: 2023 $798 · 2024 $639 · 2025 $540

Food & beverage: $540
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$127
ABBVIE INC.4$83
GlaxoSmithKline, LLC.3$48
TOLMAR, INC.2$37
Esperion Therapeutics, Inc.2$36
Lilly USA, LLC2$33
Axsome Therapeutics, Inc.1$25
Otsuka America Pharmaceutical, Inc.1$25
Phathom Pharmaceuticals, Inc.1$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$21

Products named: FARXIGA, TRELEGY ELLIPTA, BREZTRI, VRAYLAR, JATENZO, NEXLETOL, MOUNJARO, Auvelity.

Industry payments across MS — which companies pay providers there.